Stock-Based Compensation - Summary of Assumptions Used to Grant Date Fair Value Of Stock Options Granted (Details) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |
|---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Risk-free interest rate | 3.95% | 3.86% | ||
| Expected dividend yield | 0.00% | 0.00% | ||
| Expected option term (in years) | 6 years 7 days | 5 years 6 months 14 days | ||
| Expected volatility | 99.92% | 94.11% | ||
| IKENA ONCOLOGY INC | ||||
| Risk-free interest rate | 4.43% | 4.19% | 4.18% | 4.00% |
| Expected dividend yield | 0.00% | 0.00% | 0.00% | 0.00% |
| Expected option term (in years) | 5 years 6 months 29 days | 6 years 3 days | 5 years 10 months 17 days | 6 years 14 days |
| Expected volatility | 94.04% | 91.32% | 91.99% | 87.00% |